We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

145 hedge funds and large institutions have $1.95B invested in Aegerion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 145 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $123M | Put options by funds: $90.3M

Holders
145
Holders Change
+145
Holders Change %
–
% of All Funds
4.72%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
145
Increased
–
Reduced
–
Closed
–
Calls
$123M
Puts
$90.3M
Net Calls
+$33.2M
Net Calls Change
+$33.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

AEGR Hedge Fund Activity: Q2 2013 in Review

145 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q2 2013, worth a combined $1.95B.

Buyers outnumbered sellers: 145 funds opened new AEGR positions and 0 closed out — a net gain of 145 holders — while 0 added to existing stakes and 0 trimmed.

  • 145 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.95B of Aegerion Pharmaceuticals stock for Q2 2013.
  • 145 funds opened new Aegerion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +145 holders.

Based on aggregated 13F filings for Q2 2013.